Literature DB >> 5459137

The phenomenology of experimentally induced amphetamine psychosis--preliminary observations.

B M Angrist, S Gershon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5459137

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  75 in total

1.  Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo.

Authors:  J Amiel Rosenkranz; Anthony A Grace
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

Review 2.  Animal models of schizophrenia: a critical review.

Authors:  E R Marcotte; D M Pearson; L K Srivastava
Journal:  J Psychiatry Neurosci       Date:  2001-11       Impact factor: 6.186

Review 3.  Neurochemistry and behavior in man.

Authors:  G S Omenn
Journal:  West J Med       Date:  1976-12

Review 4.  Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.

Authors:  Tong H Lee; Steven T Szabo; J Corey Fowler; Paolo Mannelli; O Barry Mangum; Wayne F Beyer; Ashwin Patkar; William C Wetsel
Journal:  Drug Alcohol Depend       Date:  2012-02-21       Impact factor: 4.492

Review 5.  Disruption of cortical-limbic interaction as a substrate for comorbidity.

Authors:  A A Grace
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

Review 6.  Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models.

Authors:  Jue He; Jiming Kong; Qing-Rong Tan; Xin-Min Li
Journal:  Cell Adh Migr       Date:  2009-01-13       Impact factor: 3.405

7.  Schizophrenia: a theory.

Authors:  E Hartmann
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

8.  The effect of reserpine on concurrent repeated administration of d-amphetamine.

Authors:  G G Dougherty; E H Ellinwood
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90).

Authors:  Icro Maremmani; Pier Paolo Pani; Matteo Pacini; Jacopo V Bizzarri; Emanuela Trogu; Angelo Gi Maremmani; Gilberto Gerra; Giulio Perugi; Liliana Dell'Osso
Journal:  Ann Gen Psychiatry       Date:  2010-04-13       Impact factor: 3.455

10.  Differential regional and dose-related effects of asenapine on dopamine receptor subtypes.

Authors:  Frank I Tarazi; Taylor Moran-Gates; Erik H F Wong; Brian Henry; Mohammed Shahid
Journal:  Psychopharmacology (Berl)       Date:  2008-02-24       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.